Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
LOVher capsules pose a serious risk to your health and should not be taken.
The Therapeutic Goods Administration (TGA) has tested LOVher capsules and found that they contain:
the undisclosed substance tadalafil- consumers are advised that tadalafil is a prescription-only substance (which is the active ingredient in approved medicine Cialis)
- they also contain the undisclosed substance sildenafil
- consumers are advised that sildenafil is a prescription-only substance (which is the active ingredient in the approved medicine Viagra).
- and also contain diclofenac a non steroidal anti-inflammatory, an active ingredient in pharmacy only and prescription only medicines used in treatment of pain and inflammation associated with arthritis.
The supply of LOVher capsules is illegal.
LOVher capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
TGA investigations have shown that a number of people in Australia have bought the product online and in store.
Information for consumers
- Stop taking LOVher capsules and take any remaining capsules to your local pharmacy for safe disposal.
- If you have any concerns arising from your use of this product, consult your health care practitioner.
Action the TGA is taking
The TGA is working with Australian Customs and Border Protection Services (Customs) to help stop future shipments of LOVher capsules from entering Australia.
If these capsules are found at the border by Customs they will be seized and destroyed.
The TGA is advising consumers to exercise extreme caution when purchasing medicines from unknown overseas Internet sites. Products purchased over the Internet:
- may contain undisclosed and potentially harmful ingredients
- may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia.
Report counterfeit medicines and medical devices
If you are worried about counterfeit medicines or medical devices, and want to report an issue, you can report the matter to the TGA:
| Phone: | 1800 020 653 |
|---|---|
| Online: | Report a perceived breach of the Therapeutic Goods Act or questionable practices relating to therapeutic products |
| Email: | info@tga.gov.au |